コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 effector functions and role in infection and inflammatory disease.
2 dysregulation of this response could promote inflammatory disease.
3 to infect the endometrium, leading to pelvic inflammatory disease.
4 the progression of this lipid-driven chronic inflammatory disease.
5 s an increasingly prevalent degenerative and inflammatory disease.
6 nucleic acids by the immune system can cause inflammatory disease.
7 and understudied regulatory node in chronic inflammatory disease.
8 NOD2 could contribute to the development of inflammatory disease.
9 1) receptor-dependent, caspase-1-independent inflammatory disease.
10 inking the high-fat Western diet to systemic inflammatory disease.
11 contribute to abdominal obesity and chronic inflammatory disease.
12 response and a potential molecular target in inflammatory disease.
13 s such as wound healing, cancer, and chronic inflammatory disease.
14 e networks are dysregulated in autoimmune or inflammatory disease.
15 ring immune responses and in mouse models of inflammatory disease.
16 of lung infections, lung cancer, and chronic inflammatory disease.
17 e uveitis is a sight-threatening intraocular inflammatory disease.
18 r therapeutic potential for the treatment of inflammatory diseases.
19 tory drugs to promote tissue regeneration in inflammatory diseases.
20 vascular barriers is a major complication of inflammatory diseases.
21 ion and how this leads to the progression of inflammatory diseases.
22 new targets for treating microbiome-mediated inflammatory diseases.
23 been considered as a drug target for chronic inflammatory diseases.
24 nd is a therapeutic target for metabolic and inflammatory diseases.
25 stratification, and treatment monitoring of inflammatory diseases.
26 hat targeting Trx1 may be exploited to treat inflammatory diseases.
27 ponses but also to the development of severe inflammatory diseases.
28 important roles in atherosclerosis and other inflammatory diseases.
29 novel target for alleviating stress-induced inflammatory diseases.
30 e for apolipoproteins in the pathogenesis of inflammatory diseases.
31 ated in host defense and in the pathology of inflammatory diseases.
32 ociated with outcomes of patients with other inflammatory diseases.
33 rm of IL-1Ra, is used to treat a spectrum of inflammatory diseases.
34 ocytosis underlies a growing list of chronic inflammatory diseases.
35 gets that limit their use for autoimmune and inflammatory diseases.
36 ients harboring known variants for syndromic inflammatory diseases.
37 ar senescence, autophagy, and autoimmune and inflammatory diseases.
38 rapeutically target the chemokine network in inflammatory diseases.
39 for pain management in patients with chronic inflammatory diseases.
40 or the treatment of neuronal, metabolic, and inflammatory diseases.
41 scular risk in people with 6 immune-mediated inflammatory diseases.
42 rial infections and development of different inflammatory diseases.
43 logical conditions, including infectious and inflammatory diseases.
44 defense and resistance to the development of inflammatory diseases.
45 ental factors on the pathogenesis of chronic inflammatory diseases.
46 ronic pain is a major comorbidity of chronic inflammatory diseases.
47 , may be beneficial to patients with various inflammatory diseases.
48 kocyte recruitment and alleviating different inflammatory diseases.
49 n of PMN-associated tissue damage in chronic inflammatory diseases.
50 ased risk of AD development as well as other inflammatory diseases.
51 ical and probiotic targets in the context of inflammatory diseases.
52 gy in patients with impaired immunity and/or inflammatory diseases.
53 atherosclerosis, obesity, diabetes and other inflammatory diseases.
54 been exploited as a therapeutic for several inflammatory diseases.
55 promising novel treatment for ARDS and other inflammatory diseases.
56 factor and a validated target for immune and inflammatory diseases.
57 pathologies such as skin cancer and mucosal inflammatory diseases.
58 the efficacy of Evasins in animal models of inflammatory diseases.
59 f targeting these events therapeutically for inflammatory diseases.
60 odels and in patients afflicted with chronic inflammatory diseases.
61 asome dysregulation is a hallmark of various inflammatory diseases.
62 a fatal form of leukemia to immune-mediated inflammatory diseases.
63 show great promise for treating diabetes and inflammatory diseases.
64 a host modulation regimen to control chronic inflammatory diseases.
65 ular traps (NETs) are implicated in multiple inflammatory diseases.
66 een associated with several types of chronic inflammatory diseases.
67 nflammation and epithelial repair in chronic inflammatory diseases.
68 effects may play a role in the management of inflammatory diseases.
69 file as a blood biomarker to monitor chronic inflammatory diseases.
70 t immune molecule that is linked to multiple inflammatory diseases.
71 luence the outcome of cancer, infection, and inflammatory diseases.
72 and reflexes that are associated with airway inflammatory diseases.
73 c target in chronic wounds and other chronic inflammatory diseases.
74 s indispensable roles during type 2-mediated inflammatory diseases.
75 ue repair but can also contribute to chronic inflammatory diseases.
76 and can have an important impact on several inflammatory diseases.
77 improves the phenotype in models of chronic inflammatory diseases.
78 pha (TNF-alpha), has been implicated in many inflammatory diseases.
79 , may confer some protection against chronic inflammatory diseases.
80 which holds promise for improved efficacy in inflammatory diseases.
81 al for US stimulation of the spleen to treat inflammatory diseases.
82 y using a variety of mechanisms to attenuate inflammatory diseases.
83 is and immune defense but also contribute to inflammatory diseases.
84 ontributes to the progression of an array of inflammatory diseases.
85 ical studies for treatment of cGAS-dependent inflammatory diseases.
86 tive immunotherapeutic target for cancer and inflammatory diseases.
87 ortant factors in the mechanisms of allergic inflammatory diseases.
88 rheumatoid arthritis (RA) and other chronic inflammatory diseases.
89 backbone for anti-viral immunity and several inflammatory diseases.
90 in patients with a range of immune-mediated inflammatory diseases.
91 elioration of Th1- and Th17-mediated chronic inflammatory diseases.
92 or modulating TCR activity in autoimmune and inflammatory diseases.
93 otential to trigger or exacerbate intestinal inflammatory diseases.
94 ctivation is involved in the pathogenesis of inflammatory diseases.
95 argets for the treatment of NLRP3-associated inflammatory diseases.
96 sidered to be a newer family associated with inflammatory diseases.
97 also play a role in the pathogenesis of some inflammatory diseases.
98 d local functions in promoting Th17-mediated inflammatory diseases.
99 t initiation and progression of peri-implant inflammatory diseases.
100 rapeutic strategies to target infectious and inflammatory diseases.
101 tic process modulates phagocyte functions in inflammatory diseases.
102 el, representing 2 macrophage-driven sterile inflammatory diseases.
103 exudative retinal detachment (ERD) in ocular inflammatory diseases.
104 and PSO and discuss the association in other inflammatory diseases.
105 Ks as a new strategy for treating immune and inflammatory diseases.
106 metabolic needs of T cells to combat chronic inflammatory diseases.
107 ntribute to the development of other chronic inflammatory diseases.
108 hiregulin (AREG) as an important mediator of inflammatory diseases.
109 role in recruitment of monocytes in several inflammatory diseases.
110 ntal outcomes in immune-mediated and chronic inflammatory diseases.
111 se of JAK inhibitors to treat autoimmune and inflammatory diseases across medical subspecialties.
112 jHR]: 1.95; 95% CI: 1.13 to 3.35; p = 0.02), inflammatory disease (adjHR: 1.58; 95% CI: 1.05 to 2.36;
115 its mimics, EA is generally a self-limiting inflammatory disease and can be treated conservatively.
117 e for IL-33 in pathogenesis of anemia during inflammatory disease and define a new target for its tre
120 henotypes were available for mouse and human inflammatory diseases and assessed multiple computationa
124 aspects of repair and may be therapeutic for inflammatory diseases and defective wound healing associ
125 uracy of orbital imaging to diagnose orbital inflammatory diseases and its ability to detect active i
126 m is of huge importance, given its impact on inflammatory diseases and its potential as an easily mod
129 hways contributes to multiple autoimmune and inflammatory diseases and overexpression of a C4 isoform
130 utes a potential therapeutic target for many inflammatory diseases and represents a disease progressi
131 n increased risk of preterm delivery, pelvic inflammatory disease, and an increased risk of acquisiti
132 mechanism for fighting against infectious or inflammatory disease, and is tightly regulated by the ne
133 toxin rechallenge experiments, patients with inflammatory disease, and isolated human monocytes treat
134 lacking Tet2 and Tet3 in Treg cells develop inflammatory disease, and Treg cells from these mice sho
137 e lipids are involved in instigating chronic inflammatory diseases, and new studies have highlighted
138 ominant PET tracer in neurology, cardiology, inflammatory diseases, and, most particularly, oncology.
139 transition from asymptomatic autoimmunity to inflammatory disease are incompletely characterized.
143 ntext, patients with chronic immune-mediated inflammatory diseases are of particular interest, as the
144 n the tissue microenvironments of cancer and inflammatory diseases are similar: both are hypoxic, sho
146 cell activation, and has been implicated in inflammatory diseases as well as hematological malignanc
148 Chronic rhinosinusitis (CRS) is a chronic inflammatory disease associated with a substantial perso
149 iHS/DRESS) is a potentially fatal multiorgan inflammatory disease associated with herpesvirus reactiv
150 nflammatory bowel disease (IBD) is a chronic inflammatory disease associated with increased risk of g
152 Bone resorption is a severe consequence of inflammatory diseases associated with osteolysis, such a
153 plays a role in various diseases, including inflammatory diseases, atherosclerosis, autoimmunity, an
154 treatment of numerous conditions, including inflammatory diseases, autoimmune disorders, pain, and c
155 n host defense against pathogens but also in inflammatory diseases, autoimmunity, and cancer in infla
157 els are attractive drug targets for pain and inflammatory disease, but no subtype-selective agonists,
158 o initiate IL-1 receptor-dependent cutaneous inflammatory disease, but the source of IL-1 and the mec
159 s (ILC2s) are implicated in host defense and inflammatory disease, but these potential functional rol
160 elper 17 (Th17) cells are pathogenic in many inflammatory diseases, but also support the integrity of
161 ated hematopoiesis occurs in several chronic inflammatory diseases, but it remains unclear how hemato
162 ssue barrier fitness are predisposed towards inflammatory diseases, but most do not develop or sustai
163 immune response and plays a central role in inflammatory diseases by mediating the expression of pro
164 r cancers, organ transplantation and chronic inflammatory disease cause immunosuppression that can be
169 c lupus erythematosus (SLE) is an autoimmune inflammatory disease characterized by deposits of immune
172 r psoriasis (GPP) is a severe multi-systemic inflammatory disease characterized by neutrophilic pustu
174 herefore be an interesting target in chronic inflammatory diseases characterized by excessive neutrop
175 fers in the microenvironments of tumours and inflammatory diseases compared with normal tissues, thus
177 asing risk of infections, cancer and chronic inflammatory disease contributing to age-related multi-m
178 nocytes from RA patients, but not from other inflammatory diseases, correlated with disease activity.
179 roresolution lipid mediator whose effects on inflammatory diseases dampens pathological inflammatory
180 he cause of Chagas disease, life-threatening inflammatory diseases develop over time in the heart, es
182 hese cells essentially contribute to chronic inflammatory diseases due to their strong plasticity.
183 in mice results in the development of fatal inflammatory disease early in life, without affecting T(
184 th certain infectious agents, such as pelvic inflammatory disease, ectopic pregnancy and tubal factor
186 recently developed in rodent models to treat inflammatory disease have failed in clinical trials.
188 t increases were observed for other types of inflammatory disease (hypothyroidism, hyperthyroidism, r
191 fibrosis (CF) is a life-threatening chronic inflammatory disease in children due to respiratory comp
192 tor protein Sharpin results in a multi-organ inflammatory disease in mice characterized by chronic pr
193 riments and evaluated susceptibility to oral inflammatory disease in mice harboring distinct microbio
194 rove beneficial for the treatment of chronic inflammatory diseases in combination with cytokine-block
195 re associated with an increased incidence of inflammatory diseases in humans, yet whether and how tel
197 healers for the treatment of infectious and inflammatory diseases in the Greater Mpigi region of Uga
198 marker of systemic inflammation and risk of inflammatory disease, in 222 euthymic BD patients and 52
199 ation and homeostasis and are key targets in inflammatory diseases including atherosclerosis, cytokin
201 its central position in the pathogenesis of inflammatory diseases including psoriasis were discovere
202 TNF plays a key role in immune-mediated inflammatory diseases including rheumatoid arthritis (RA
203 ess is fundamental to innate immunity and to inflammatory disease, including atherosclerosis, where m
204 12 (MMP-12) is highly upregulated in several inflammatory diseases, including abdominal aortic aneury
205 n of soluble epoxide hydrolase (sEH) reduces inflammatory diseases, including acute pancreatitis (AP)
206 n of T(H)17 cells is associated with several inflammatory diseases, including inflammatory bowel dise
207 is concomitant with pathogenesis of several inflammatory diseases, including metabolic syndrome, but
209 ignaling is reduced in patients with chronic inflammatory diseases, including systemic lupus erythema
210 ses local drug delivery systems in different inflammatory diseases, including the targets well-known
211 Prolonged TNF release causes many chronic inflammatory diseases, indicating that tight regulation
212 ent, leading to complications such as pelvic inflammatory disease, infertility, and ectopic pregnancy
213 Serious consequences of STIs include pelvic inflammatory disease, infertility, cancer, and AIDS.
215 (EA) is a relatively rare, benign and local inflammatory disease involving the epiploic appendices.
216 roenvironment of tissues affected by chronic inflammatory disease is pro-inflammatory and anti-resolu
217 The risk of HTLV-1-associated malignancy and inflammatory disease is strongly correlated with provira
218 is known, ulcerative colitis (UC), a chronic inflammatory disease, is closely related to immune dysfu
223 own etiology and initial similarity to other inflammatory diseases makes early diagnosis a significan
224 s suggests an LNP which delivers mRNA to one inflammatory disease may not deliver mRNA to another.
225 sease mice through bacterial infection as an inflammatory disease model and used adeno-associated vir
226 has been shown to be beneficial in multiple inflammatory disease models with the effects largely att
229 ase-2 (COX-2) overexpression is prominent in inflammatory diseases, neurodegenerative disorders, and
233 Multiple sclerosis (MS) is an autoimmune inflammatory disease of the CNS driven by the inflammato
237 l role in sepsis, along with a host of other inflammatory diseases of chronic, noninfectious origin.
238 ental autoimmune encephalomyelitis (EAE) are inflammatory diseases of the CNS in which Th17 cells pla
242 ondyloarthritis (SpA) represents a family of inflammatory diseases of the spine and peripheral joints
243 tes in the sinonasal cavity, with non-type 2 inflammatory disease on one end, type 2 inflammatory, eo
244 For diagnostic distinction between a chronic inflammatory disease or a neoplasm, exploratory laparoto
245 on and diagnostic distinction from a chronic inflammatory disease or other neoplasm is only possible
247 f macrophage activation is needed to prevent inflammatory disease, particularly at barrier sites such
248 ted macrophage polarization is important for inflammatory disease pathogenesis, but the mechanisms re
250 cytes from NOMID (neonatal onset multisystem inflammatory disease) patients who have NLRP3 mutations
251 elated to IUC use (n = 7) comprised 3 pelvic inflammatory disease (PID) cases and 4 pregnancies with
252 incidence, and chlamydia-attributable pelvic inflammatory disease (PID) incidence, assuming status qu
253 omen, chlamydial infections may cause pelvic inflammatory disease (PID), ectopic pregnancy, and infer
255 nts to individuals with rheumatic autoimmune inflammatory diseases (RAIDs), often by 'borrowing' trea
258 lation of TLR9 early in life drives a severe inflammatory disease resulting in neonatal fatality.
266 mast cells contribute to a number of chronic inflammatory diseases such as periodontitis, neurogenic
267 into early clinical trials for evaluation in inflammatory diseases such as psoriasis, rheumatoid arth
268 lammatory signals associated with intestinal inflammatory diseases, such as ulcerative colitis and Cr
269 as two medications approved for treatment of inflammatory diseases, sulfasalazine and the antifolate
271 -vs-host disease (cGVHD) is a multifactorial inflammatory disease that affects patients undergoing he
272 ildren, some children later develop a severe inflammatory disease that can have manifestations simila
274 Eosinophilic esophagitis (EoE) is a chronic inflammatory disease that has been known since the early
276 Periodontitis (PD) is a common dysbiotic inflammatory disease that leads to local bone deteriorat
277 Otitis media with effusion (OME) is a common inflammatory disease that primarily affects children.
278 tis (UC) is one of the main types of chronic inflammatory diseases that affect the bowel, but its pat
279 of these cell types is perturbed in chronic inflammatory diseases that are associated with impaired
280 dosis but also for several of the underlying inflammatory diseases that cause amyloid A amyloidosis h
281 2), which are associated with severe chronic inflammatory diseases that span several organ systems(3-
282 on route, particularly in tumors and chronic inflammatory disease, these findings may help to refine
284 advances in the treatment of autoimmune and inflammatory diseases, unmet medical needs in some areas
285 alium infections in women progress to pelvic inflammatory disease versus 14.4% (5.9-24.6%) of chlamyd
286 des showing thickened cortex due to systemic inflammatory diseases was over 1, and there was a statis
287 evaluated as a therapeutic agent in various inflammatory diseases, we examined if exogenous RvD1 cou
288 d as important mediators of tissue damage in inflammatory diseases, we investigated whether NETs woul
289 eir potential as biological therapeutics for inflammatory diseases, we sought to further unravel the
290 BD, n = 40, F:M = 29:11) as another systemic inflammatory disease were studied along with a systemica
291 eased levels of putative markers for several inflammatory diseases, which were reduced by the benzimi
292 hedgehog (SHH) stabilizes the BBB during CNS inflammatory disease, while endothelial-derived desert h
293 ng of the metabolic signature of tumours and inflammatory diseases will enable therapeutic interventi
294 ic esophagitis (EoE) is an allergen-mediated inflammatory disease with no approved treatment in the U
296 sease (IBD) are both chronic immune-mediated inflammatory diseases with an overlapping genetic profil
298 the importance of considering infectious and inflammatory disease within a conceptual framework that
299 ss is associated with many acute and chronic inflammatory diseases, yet limited treatment is currentl